Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research report sent to investors on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s ...

The number of New Yorkers prescribed a key medication for opioid use disorder increased 7% during the pandemic as health providers battled against skyrocketing drug overdose deaths, a state report ...

In a recent study, majority non-White communities had at least 40 percent lower mean adjusted per-capita distribution than majority White communities.

A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted ...

Researchers at University of the Pacific in Stockton have developed a long-acting opioid overdose-reversal drug-delivery system that could save lives.

Despite an increase in the use of medication for opioid use disorder in older adults from 2017 to 2022, disparities persist; ...

An online-based mindfulness treatment program significantly reduced opioid craving among participants with opioid use disorder results from a randomized clinical trial published in JAMA Network Open ...

The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...

Hydromorphone, a type of opioid, is pictured at a managed opioid program in 2019. The drug is among those whose prescriptions have dramatically increased in recent years. The province is ...